Use of alkylated iminosugars to treat multidrug resistance
US6225325A · kind A · utility
Assignee
Inventor
Key dates
| Filing date | Nov 10, 1998 |
| Grant date | May 1, 2001 |
| Priority date | — |
| Expiry date | Nov 10, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
RACT). Fischl, M., et al., The Preliminary Efficacy and Safety of N-Butyl Deoxynojirimycin (SC-48334), an alpha-Glucosidase 1 Inhibitor, in Combination with Ziduvudine (ZDV), International Conference on Aids IXth (9th) International Conference on Aids in affiliation with the IVth (4th) STD World Congress, Berlin, Jun. 6-11th, 1993. Ratner, L., et al., Mechanism of Action of N-Butyl Deoxynojirimycin in Inhibiting HIV-1 Infection and Activity in Combination with Nucleoside Analogs, Aids Research and Human Retroviruses, vol. 9, No. 4, 1993, pp. 291-297. Myers, M.W., New Antiretroviral Agents in the Clinic, Reviews of Infectious Diseases, vol. 12, No. 5, Sep.-Oct. 1990, pp. 944-950. Acosta, E.P. et al., Agents for Treating Human Immunodeficiency Virus Infection, American Journal of Hospital Pharmacy, vol. 51, No. 18, Sep. 15, 1994, pp. 2251-2287. Gasparini, G et al., Cinical Importance of the Determination of Tumor Angiogenesis in Breast Carcinoma: Much More Than a New Prognostic Tool, Journal of Clinincal Oncology, The Official Journal of the American Society of Clinical Oncology, vol. 13, No. 3, Mar. 1995, pp. 765-782. Jacob, G.S., Glycosylation Inhibitors in Biology and Medicine, Cu…
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.